Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease

Author:

Ku Elaine1ORCID,Inker Lesley A.2,Tighiouart Hocine3ORCID,McCulloch Charles E.4,Adingwupu Ogechi M.2ORCID,Greene Tom5,Estacio Raymond O.6,Woodward Mark7ORCID,de Zeeuw Dick8ORCID,Lewis Julia B.9ORCID,Hannedouche Thierry10ORCID,Jafar Tazeen H.11ORCID,Imai Enyu12,Remuzzi Giuseppe13ORCID,Heerspink Hiddo J.L.14ORCID,Hou Fan Fan15ORCID,Toto Robert D.16ORCID,Li Philip K.17ORCID,Sarnak Mark J.2ORCID

Affiliation:

1. Departments of Medicine and Pediatrics, Division of Nephrology, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California (E.K.)

2. Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts (L.A.I., O.M.A., M.J.S.)

3. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts (H.T.)

4. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California (C.E.M.)

5. Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah (T.G.)

6. Ambulatory Care Services, Denver Health, and Department of General Internal Medicine, University of Colorado at Denver, Health Sciences Center, Denver, Colorado (R.O.E.)

7. The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia, and The George Institute for Global Health, School of Public Health, Imperial College London, London, United Kingdom (M.W.)

8. Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, the Netherlands (D.deZ.)

9. Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee (J.B.L.)

10. University of Strasbourg, AURAL, Strasbourg, France (T.H.)

11. Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore (T.H.J.)

12. Nakayamadera Imai Clinic, Takarazuka, Japan (E.I.)

13. Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy (G.R.)

14. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.)

15. Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, Guangzhou, China (F.F.H.)

16. University of Texas Southwestern Medical Center, Dallas, Texas (R.D.T.)

17. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China (P.K.L.).

Publisher

American College of Physicians

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Diabetic kidney disease—Recent updates;Journal of Diabetes;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3